X @The Economist
The Economist·2026-07-26 20:00
Some 22% of American women and 14% of men have taken GLP-1s for weight loss or for chronic conditions such as diabetes. In charts we show the social and economic effects https://t.co/7Pvg34x5gD ...
Some 22% of American women and 14% of men have taken GLP-1s for weight loss or for chronic conditions such as diabetes. In charts we show the social and economic effects https://t.co/7Pvg34x5gD ...